DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rituxan (Rituximab) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (180)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 180   Next >>

Possible Rituxan side effects in 39 year old female

Reported by a pharmacist from United States on 2012-08-23

Patient: 39 year old female, weighing 82.6 kg (181.6 pounds)

Reactions: Dyspnoea, Vomiting, Chest Discomfort, Pruritus, Nausea, Rash, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Prednisone; Pyroxidine; Calcium; Folic Acid; Leucovorin Calcium; Methotrexate; Ibuprofen; Lisinopril; Diazepam; Fexofenadine; Pantoprazole; Acetaminophen; Diphenhydramine Hydrochloride; Multi-Vitamin



Possible Rituxan side effects in male

Reported by a pharmacist from United States on 2012-08-20

Patient: male

Reactions: Tachycardia, Blood Pressure Decreased, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: female

Reactions: Pruritus, Visual Impairment, Oral Disorder, Psoriasis, Gingival Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-20

Patient: female, weighing 70.4 kg (154.9 pounds)

Reactions: Movement Disorder, Dyspnoea, Local Swelling

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1280 mg

Doxorubicin Hydrochloride
    Dosage: 86 mg

Prednisone
    Dosage: 70 mg

Rituxan
    Dosage: 650 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Rituxan side effects in

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient:

Reactions: Weight Decreased, Unwanted Awareness During Anaesthesia, Dyspnoea, Lower Limb Fracture, Paraesthesia, Tremor, Irritability, Fatigue, Balance Disorder, Dizziness, Ulcer Haemorrhage, Papilloma Viral Infection, Nervousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan
    Indication: non-Hodgkin's Lymphoma
    Start date: 2005-01-01

Rituxan
    Dosage: late dec/2011 or jan/2012



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-16

Patient: male, weighing 84.7 kg (186.3 pounds)

Reactions: Splenic Vein Thrombosis, Venous Haemorrhage, Iatrogenic Injury, Splenic Neoplasm Malignancy Unspecified, Platelet Count Decreased, Gastric Varices, Haemorrhagic Ascites, Venous Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1520 mg

Doxorubicin Hydrochloride
    Dosage: 101 mg

Prednisone TAB
    Dosage: 400 mg

Rituxan
    Dosage: 758 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: female

Reactions: Thrombosis, RED Blood Cell Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Procrit
    Indication: Product Used FOR Unknown Indication

Rituxan
    Indication: Rheumatoid Arthritis



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-16

Patient: male, weighing 84.7 kg (186.3 pounds)

Reactions: Splenic Vein Thrombosis, Abdominal Distension, Haemorrhagic Ascites, Venous Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1520 mg

Doxorubicin Hydrochloride
    Dosage: 101 mg

Prednisone
    Dosage: 400 mg

Rituxan
    Dosage: 758 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male, weighing 91.7 kg (201.7 pounds)

Reactions: Pneumonia, Anaemia, Pancytopenia, Febrile Neutropenia, Respiratory Failure, Muscle Abscess, Thrombocytopenia, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: 150 milligram
    Start date: 2012-05-14

Rituxan
    Start date: 2012-06-22

Rituxan
    Start date: 2012-07-19
    End date: 2012-07-20

Rituxan
    Dosage: 17.8571 milligram
    Start date: 2012-08-04

Vidaza
    Dosage: 150 milligram
    Start date: 2012-05-14

Vidaza
    Dosage: 150 milligram
    Start date: 2012-07-19
    End date: 2012-07-20

Other drugs received by patient: Procrit; Fluticasone Propionate; Folic Acid; Hydrocortisone-Pramoxine; Metoprolol Tartrate; Rosuvastatin; Meropenem; Vancomycin; Dextrose; Acetaminophen; Calcium + Vitamin D; Ciprofloxacin-Dexamethasone Otic; Diphenhydramine Hydrochloride; Filgrastim; Multi-Vitamins; Phenylephrine Hydrochloride; Acetaminophen; Naproxen; Whole Blood; Prednisone TAB; Vitamin B-12; Acetaminophen; Benazepril Hydrochloride; Augmentin '500'; Amlodipine; Omeprazole; Sodium Chloride



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-14

Patient: male

Reactions: Aphasia, Unevaluable Event, Hemiparesis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in

Reported by a physician from China on 2012-08-14

Patient:

Reactions: Dyspnoea, Hyperpyrexia, Tachycardia, Oliguria, Altered State of Consciousness, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: male

Reactions: Dyspnoea, Balance Disorder, Dizziness, Ulcer Haemorrhage, Tremor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 70 year old

Reported by a pharmacist from United States on 2012-08-09

Patient: 70 year old

Reactions: Death, Histiocytosis Haematophagic, Chills

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Indication: Lymphoma
    Start date: 2012-05-14

Bendamustine Hydrochloride
    Start date: 2012-05-15

Rituxan
    Dosage: splitted dose.
    Start date: 2012-05-15

Rituxan
    Indication: Lymphoma
    Start date: 2012-05-14



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-09

Patient: female

Reactions: Pneumonia, Diabetes Mellitus, Drug Ineffective, Condition Aggravated, Chronic Obstructive Pulmonary Disease, Dyspepsia, Oedema Peripheral, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Start date: 2011-11-30

Prednisone TAB
    Dosage: dose-variable. dose started years ago
    Administration route: Oral
    Indication: Vasculitis

Rituxan
    Indication: Wegener's Granulomatosis
    Start date: 2006-01-01

Rituxan
    Indication: Vasculitis
    Start date: 2011-08-25
    End date: 2011-09-16

Other drugs received by patient: Simvastatin; Cellcept; Lisinopril; Metformin Hydrochloride



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-07

Patient: male

Reactions: Malaise, Human Antichimeric Antibody Positive, Nuclear Magnetic Resonance Imaging Abnormal, B-Lymphocyte Count Decreased, Ill-Defined Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: treatment given once and repeated 2 weeks later.
    Indication: Ill-Defined Disorder
    Start date: 2010-10-01

Rituxan
    Dosage: given once.
    Start date: 2011-04-01

Rituxan
    Dosage: given once.
    Start date: 2012-03-01

Rituxan
    Dosage: treatment repeated 1 week later
    Start date: 2011-01-01

Rituxan
    Dosage: given once.
    Start date: 2011-10-01



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female, weighing 141.5 kg (311.3 pounds)

Reactions: Leukocytoclastic Vasculitis, Hypotension, Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 1 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-25

Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Pneumonia Fungal, Electrocardiogram QT Prolonged, Renal Disorder, Malnutrition, Disseminated Intravascular Coagulation, Clostridium Colitis, Gastric Ulcer, Pneumonia Cytomegaloviral, Liver Disorder, Hypokalaemia, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: uncertainty

Bactrim
    Dosage: unk

Cellcept
    Dosage: uncertainty
    Administration route: Oral

Cyclosporine
    Dosage: uncertainty

Decadron
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-05-20
    End date: 2011-06-17

Funguard
    Dosage: uncertainty

Meropenem
    Dosage: unk
    Indication: Prophylaxis

Rituxan

Romiplostim
    Dosage: 1 mg/kg, qwk
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-06-01
    End date: 2011-06-08

Romiplostim
    Dosage: 2 mg/kg, qwk
    Start date: 2011-06-15
    End date: 2011-06-15

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2011-06-24
    End date: 2012-06-24

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-08-09
    End date: 2011-08-09

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-07-21
    End date: 2011-08-06

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-10-17

Romiplostim
    Dosage: 9 mg/kg, qwk
    Start date: 2011-09-08
    End date: 2011-09-08

Romiplostim
    Dosage: 4 mg/kg, qwk
    Start date: 2011-07-11
    End date: 2011-07-11

Romiplostim
    Dosage: 8 mg/kg, qwk
    Start date: 2011-09-01
    End date: 2011-09-01

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2012-06-21
    End date: 2012-06-21

Romiplostim
    Dosage: 6 mg/kg, qwk
    Start date: 2011-08-16
    End date: 2011-08-16

Romiplostim
    Dosage: 7 mg/kg, qwk
    Start date: 2011-08-24
    End date: 2011-08-24

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-09-15
    End date: 2011-10-13

Zosyn
    Dosage: unk

Other drugs received by patient: Prednisolone; Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Famotidine; Danazol; Danazol; Immune Globulin (Human); Cefazolin Sodium; Prednisolone; Prednisolone; Prednisolone; Prednisolone



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-07-23

Patient: male

Reactions: Rash Generalised, Oedema, Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-24

Bendamustine Hydrochloride
    Start date: 2012-05-25

Rituxan
    Indication: Mantle Cell Lymphoma



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-07-23

Patient: male

Reactions: Rash Generalised, Oedema, Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Start date: 2012-05-25

Bendamustine Hydrochloride
    Indication: Mantle Cell Lymphoma
    Start date: 2012-05-24

Rituxan
    Indication: Mantle Cell Lymphoma



Possible Rituxan side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20

Patient: 66 year old female, weighing 85.8 kg (188.8 pounds)

Reactions: Atrial Fibrillation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: every 28 days
    Start date: 2012-03-23
    End date: 2012-05-03

Treanda
    Dosage: every 28 days
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-03-23
    End date: 2012-05-02



Possible Rituxan side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carmustine
    Dosage: day - 7

Cytarabine
    Dosage: day -6 til day -3

Etoposide
    Dosage: day -6 till day -3

Melphalan Hydrochloride
    Dosage: day -2

Rituxan
    Dosage: day - 19 and day - 12

Velcade
    Dosage: d2 and d8
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-05-01

Vorinostat
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-30
    End date: 2012-05-06

Other drugs received by patient: Zovirax; Diphenhydramine HCL; Loperamide HCL; Dapsone; Compazine; Cholecalciferol; Allegra; Citalopram Hydrobromide; Bactrim; Potassium Chloride; Vitamin D (Unspecified); Potassium Bicarbonate; Nystatin; Lorazepam; Zofran; Folic Acid; Vitamins (Unspecified)



Possible Rituxan side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-17

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Weight Decreased, Oral Candidiasis, Dehydration, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1320 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Cyclophosphamide
    Dosage: 1350 mg, unk
    Start date: 2012-01-23

Cyclophosphamide
    Dosage: 1275 mg, unk
    Start date: 2012-02-13

Doxorubicin HCL
    Dosage: 88 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Doxorubicin HCL
    Dosage: 90 mg, unk
    Start date: 2012-01-23

Doxorubicin HCL
    Dosage: 85 mg, unk
    Start date: 2012-02-13

Pegfilgrastim
    Dosage: 6 mg, unk
    Start date: 2012-02-14

Pegfilgrastim
    Dosage: 6 mg, unk
    Start date: 2012-01-28

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-10

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-01-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-02-13

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-02-17

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-23

Rituxan
    Dosage: 600 mg, unk
    Start date: 2012-02-18

Rituxan
    Dosage: 600 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Rituxan
    Dosage: 700 mg, unk
    Start date: 2012-01-23

Vincristine
    Dosage: 42 mg, unk
    Start date: 2012-01-23

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Vincristine
    Dosage: 2 mg
    Start date: 2012-02-13

Other drugs received by patient: Morphine Sulfate; Pantoprazole; Mirtazapine; Tenoretic; Simvastatin; Venlafaxine Hydrocholride; Simvastatin; Simvastatin



Possible Rituxan side effects in 78 year old female

Reported by a physician from Denmark on 2012-07-16

Patient: 78 year old female, weighing 58.0 kg (127.6 pounds)

Reactions: Weight Decreased, Oral Candidiasis, Dehydration, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1320 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09
    End date: 2012-01-01

Cyclophosphamide
    Dosage: 1350 mg, unk
    Start date: 2012-01-23
    End date: 2012-01-01

Cyclophosphamide
    Dosage: 1275 mg, unk
    Start date: 2012-02-13

Doxorubicin HCL
    Dosage: 88 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Doxorubicin HCL
    Dosage: 90 mg, unk
    Start date: 2012-01-23
    End date: 2012-01-01

Doxorubicin HCL
    Dosage: 85 mg, unk
    Start date: 2012-02-13

Neupogen
    Dosage: 6 mg, unk
    Start date: 2012-02-14

Neupogen
    Dosage: 6 mg, unk
    Start date: 2012-01-10

Neupogen
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-01-28
    End date: 2012-01-01

Pegfilgrastim
    Dosage: 6 mg, unk
    Start date: 2012-02-14

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-10

Pegfilgrastim
    Dosage: 6 mg, unk
    Start date: 2012-01-28
    End date: 2012-01-01

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-01-23
    End date: 2012-01-01

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-02-13
    End date: 2012-02-01

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09
    End date: 2012-01-01

Prednisone
    Dosage: 50 mg, day 6

Prednisone
    Dosage: 10 mg, day 8

Prednisone
    Dosage: 25 mg, day 7

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-02-17

Rituxan
    Dosage: 600 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Rituxan
    Dosage: 700 mg, unk
    Start date: 2012-01-23

Rituxan
    Dosage: 600 mg, unk
    Start date: 2012-02-18

Vincristine
    Dosage: 2 mg, unk
    Start date: 2012-02-13

Vincristine
    Dosage: 42 mg, unk
    Start date: 2012-01-23
    End date: 2012-01-01

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09
    End date: 2012-01-01

Other drugs received by patient: Mirtazapine; Simvastatin; Pantoprazole; Simvastatin; Simvastatin; Simvastatin; Tenoretic; Venlafaxine Hydrochloride; Morphine Sulfate



Possible Rituxan side effects in 68 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 68 year old male, weighing 93.4 kg (205.6 pounds)

Reactions: Dyspnoea, Musculoskeletal Pain, Pancytopenia, Febrile Neutropenia, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: 750 milligram
    Start date: 2012-06-22

Rituxan

Vidaza

Vidaza
    Dosage: 150 milligram
    Start date: 2012-05-14



Possible Rituxan side effects in 1 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13

Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Electrocardiogram QT Prolonged, Pneumonia Fungal, Renal Disorder, Disseminated Intravascular Coagulation, Malnutrition, Gastric Ulcer, Clostridium Colitis, Pneumonia Cytomegaloviral, Hypokalaemia, Liver Disorder, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: uncertainty

Bactrim
    Dosage: unk

Cellcept
    Dosage: uncertainty
    Administration route: Oral

Cyclosporine
    Dosage: uncertainty

Decadron
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-05-20
    End date: 2011-06-17

Funguard
    Dosage: uncertainty

Meropenem
    Dosage: unk
    Indication: Prophylaxis

Rituxan

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2011-06-24
    End date: 2012-06-24

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-09-15
    End date: 2011-10-13

Romiplostim
    Dosage: 2 mg/kg, qwk
    Start date: 2011-06-15
    End date: 2011-06-15

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-07-21
    End date: 2011-08-06

Romiplostim
    Dosage: 6 mg/kg, qwk
    Start date: 2011-08-16
    End date: 2011-08-16

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-08-09
    End date: 2011-08-09

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-10-17

Romiplostim
    Dosage: 8 mg/kg, qwk
    Start date: 2011-09-01
    End date: 2011-09-01

Romiplostim
    Dosage: 9 mg/kg, qwk
    Start date: 2011-09-08
    End date: 2011-09-08

Romiplostim
    Dosage: 4 mg/kg, qwk
    Start date: 2011-07-11
    End date: 2011-07-11

Romiplostim
    Dosage: 1 mg/kg, qwk
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-06-01
    End date: 2011-06-08

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2012-06-21
    End date: 2012-06-21

Romiplostim
    Dosage: 7 mg/kg, qwk
    Start date: 2011-08-24
    End date: 2011-08-24

Zosyn
    Dosage: unk

Other drugs received by patient: Danazol; Famotidine; Prednisolone; Prednisolone; Danazol; Prednisolone; Cefazolin Sodium; Prednisolone; Immune Globulin (Human); Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Prednisolone



Possible Rituxan side effects in female

Reported by a physician from France on 2012-07-12

Patient: female, weighing 58.7 kg (129.1 pounds)

Reactions: Hypoglycaemia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Mantle Cell Lymphoma

Rituxan
    Indication: Mantle Cell Lymphoma

Treanda
    Indication: Mantle Cell Lymphoma

Velcade
    Indication: Mantle Cell Lymphoma



Possible Rituxan side effects in 46 year old male

Reported by a physician from United States on 2012-07-12

Patient: 46 year old male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 446 mg, unk

Cyclophosphamide
    Dosage: 630 mg, q12h
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17

Doxorubicin HCL
    Dosage: 56.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Doxorubicin HCL
    Dosage: 37 mg, unk

Mesna
    Dosage: 1116 mg, unk
    Indication: non-Hodgkin's Lymphoma

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituxan
    Dosage: 698 mg, unk
    Start date: 2012-05-02

Rituxan
    Dosage: 787.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine Sulfate
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17

Other drugs received by patient: MS Contin; Valtrex; Omeprazole; Ciprofloxacin; Morphine Sulfate; Enoxaparin / 01708202 /; Compazine; Fluconazole; Metoprolol Tartrate



Possible Rituxan side effects in 82 year old female

Reported by a physician from France on 2012-07-10

Patient: 82 year old female

Reactions: Hypertension, Transient Ischaemic Attack

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Corticoid; Paroxetine HCL; Alendronate Sodium; Diltiazem HCL



Possible Rituxan side effects in male

Reported by a physician from Germany on 2012-07-10

Patient: male

Reactions: Neutropenia, Lymphocytic Infiltration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Doxorubicin HCL
    Dosage: 100 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Neulasta
    Dosage: 6 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-20
    End date: 2012-04-20

Prednisolone
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-21

Rituxan
    Dosage: 750 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-16

Vincristine
    Dosage: 2 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Other drugs received by patient: Morphine Sulfate; Acyclovir; Metoclopramide; Dipyrone TAB; Pantoprazole



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10

Patient: male, weighing 48.5 kg (106.8 pounds)

Reactions: Myoclonus

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: 220 mg, single
    Indication: Multiple Myeloma
    Start date: 2012-06-06
    End date: 2012-06-06

Rituxan
    Dosage: 220 mg, single
    Start date: 2012-05-30
    End date: 2012-05-30

Zevalin
    Dosage: 30.4 mci, single
    Indication: Multiple Myeloma
    Start date: 2012-06-06
    End date: 2012-06-06

Zevalin
    Dosage: 5.493 mci, single
    Start date: 2012-05-30
    End date: 2012-05-30

Other drugs received by patient: Folic Acid; Dexamethasone; Metoprolol; K-Phos Premix; Lasix; Magnesium Sulfate; Sodium Bicarbonate; Aspirin; Gabapentin; Nifedipine; Crestor; Ondansetron; Protonix; Melphalan Hydrochloride; Isosorbide Mononitrate; K-Phos Neutral; Levothyroxine Sodium



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017